Zhang W, Han X, Yang L, Song Y, et al. Safety, pharmacokinetics and efficacy of SCT200, an anti-EGFR monoclonal antibody
in patients with wild-type KRAS/NRAS/BRAF metastatic colorectal cancer: a phase I
dose-escalation and dose-expansion study. BMC Cancer 2022;22:1104.
PMID: 36307775